Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-21

FDA Approved: BUSULFAN — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Busulfan by Amneal Pharmaceuticals LLC, updating the approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUSULFAN (Busulfan)

Snippet

SUPPL AP for BUSULFAN (BUSULFAN)